Third Harmonic Bio, Inc.
THRD
$5.15
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 18.06% | 11.92% | 5.86% | 7.23% | 16.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.65% | 33.94% | 12.18% | 3.95% | 3.21% |
| Operating Income | -48.65% | -33.94% | -12.18% | -3.95% | -3.21% |
| Income Before Tax | -80.59% | -47.51% | -10.49% | 9.90% | 18.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -80.59% | -47.51% | -10.49% | 9.90% | 18.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -80.59% | -47.51% | -10.49% | 9.90% | 18.82% |
| EBIT | -48.65% | -33.94% | -12.18% | -3.95% | -3.21% |
| EBITDA | -48.68% | -33.94% | -12.13% | -28.48% | -69.23% |
| EPS Basic | -67.30% | -40.39% | -8.15% | 49.23% | 76.61% |
| Normalized Basic EPS | -61.33% | -40.39% | -8.14% | 49.24% | 76.61% |
| EPS Diluted | -67.30% | -40.39% | -8.15% | 49.23% | 76.61% |
| Normalized Diluted EPS | -61.33% | -40.39% | -8.14% | 49.24% | 76.61% |
| Average Basic Shares Outstanding | 7.70% | 4.75% | 1.81% | 24.77% | 70.80% |
| Average Diluted Shares Outstanding | 7.70% | 4.75% | 1.81% | 24.77% | 70.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |